Key result
Hypoattenuated leaflet thickening occurs in 10-40% of TAVR patients and frequently prompts anticoagulation, though its long-term association with mortality and stroke remains unsettled.
Why the study?
Does hypoattenuated leaflet thickening (HALT) affect the risk of mortality or stroke in TAVR patients?
Does hypoattenuated leaflet thickening (HALT) affect the risk of mortality or stroke in TAVR patients?
This meta-analysis aims to determine the unsettled long-term association between hypoattenuated leaflet thickening (HALT) and the risk of mortality or stroke after TAVR.
Hypoattenuated leaflet thickening (HALT) occurs in 10-40% of TAVR patients and frequently prompts initiation or escalation of anticoagulation, yet its long-term association with mortality and stroke remains unsettled.
No takes yet. Share an insight, caveat, or question.
Menda et al. (2026) studied this question. Hypoattenuated leaflet thickening occurs in 10-40% of TAVR patients and frequently prompts anticoagulation, though its long-term association with mortality and stroke remains unsettled.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: